Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
To investigate whether a treatment with quetiapine for six months in patients with
first-episode psychosis may be effective in treating depressive symptoms.
To investigate whether a treatment with quetiapine for six months in patients with
first-episode psychosis may be effective in mania-like symptoms and to evaluate the general
efficacy in psychopathology as well as the safety and tolerability of quetiapine.
Phase:
Phase 4
Details
Lead Sponsor:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH